Comparative activity of imipenem (N-formimidoyl thienamycin) on enterococci and its interactions with aminoglycosides
- PMID: 6423613
- DOI: 10.1093/jac/13.2.129
Comparative activity of imipenem (N-formimidoyl thienamycin) on enterococci and its interactions with aminoglycosides
Abstract
Activity of imipenem (N-formimidoyl thienamycin, ampicillin and vancomycin against 27 Streptococcus faecalis and 5 Str. faecium was determined. Also evaluated were the interactions of imipenem, ampicillin and vancomycin with streptomycin or amikacin or sissomicin. Imipenem showed the most inhibitory activity against Str. faecalis with MIC50 and MIC90 values 0.5 and 2 mg/l respectively, Str. faecium strains were less susceptible to imipenem with MIC50/MIC90 values of 2/16 mg/l. Imipenem showed good bactericidal activity against both groups of strains with MBC50/MBC90 values of 1/4 and 4/16 mg/l respectively. The most favourable interactions (synergy and addition) of imipenem were with streptomycin (72.2%) and sissomicin (53.2%). Combinations containing amikacin were the least favourable. Similar results were obtained with these combinations against Str. faecium.
Similar articles
-
Comparative killing activity and postantibiotic effect of streptomycin combined with ampicillin, ciprofloxacin, imipenem, piperacillin or vancomycin against strains of Streptococcus faecalis and Streptococcus faecium.Chemotherapy. 1988;34(3):229-34. doi: 10.1159/000238574. Chemotherapy. 1988. PMID: 3138078
-
Synergistic effect of N-formimidoyl thienamycin with gentamicin and amikacin against Streptococcus faecalis.Antimicrob Agents Chemother. 1983 Feb;23(2):245-7. doi: 10.1128/AAC.23.2.245. Antimicrob Agents Chemother. 1983. PMID: 6404218 Free PMC article.
-
Susceptibility of enterococci and Listeria monocytogenes to N-Formimidoyl thienamycin alone and in combination with an aminoglycoside.Antimicrob Agents Chemother. 1981 May;19(5):789-93. doi: 10.1128/AAC.19.5.789. Antimicrob Agents Chemother. 1981. PMID: 6794445 Free PMC article.
-
Synergy of imipenem or penicillin G and aminoglycosides against enterococci isolated from patients with infective endocarditis.Antimicrob Agents Chemother. 1984 Dec;26(6):909-12. doi: 10.1128/AAC.26.6.909. Antimicrob Agents Chemother. 1984. PMID: 6596907 Free PMC article.
-
Antimicrobial resistance among enterococci.Antimicrob Agents Chemother. 1991 Jan;35(1):1-4. doi: 10.1128/AAC.35.1.1. Antimicrob Agents Chemother. 1991. PMID: 1901693 Free PMC article. Review. No abstract available.
Cited by
-
Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.Drugs. 1987 Mar;33(3):183-241. doi: 10.2165/00003495-198733030-00001. Drugs. 1987. PMID: 3552595 Review.
-
In vitro activity of imipenem against enterococci and staphylococci and evidence for high rates of synergism with teicoplanin, fosfomycin, and rifampin.Antimicrob Agents Chemother. 1986 Nov;30(5):813-5. doi: 10.1128/AAC.30.5.813. Antimicrob Agents Chemother. 1986. PMID: 2948444 Free PMC article.
-
In vitro activity of imipenem--a review.Eur J Clin Microbiol. 1984 Oct;3(5):456-62. doi: 10.1007/BF02017375. Eur J Clin Microbiol. 1984. PMID: 6389125 Review.
-
Pharmacokinetics of imipenem-cilastatin in neonates.Antimicrob Agents Chemother. 1985 Apr;27(4):431-5. doi: 10.1128/AAC.27.4.431. Antimicrob Agents Chemother. 1985. PMID: 3859242 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical